Abstract:We recently published biochemical and quantitative evidence that challenges the widespread claims that PRC2 binds directly to many RNAs in vivo. A recent preprint performs a re-analysis of some of our data using a different metric and claims to identify contradictory results: that PRC2 binds to more RNAs than the well-characterized PTBP1 and SAF-A RNA-binding proteins. The preprint also reports other counterintuitive observations, including that PRC2, and all proteins examined, bind to RNAs that do not exist within the same cell and therefore could not interact in vivo nor could they be UV-crosslinked. Because these observations are incongruent with orthogonal, non-PCR based, measurements as well as fundamental RNA biology, we explored why their analysis would lead to these unexpected observations. After carefully examining the methods used and regenerating the reported results, we found a very simple explanation for these discrepancies: the authors effectively ignore the vast majority of RNAs in the sample. Here we show that this failure to properly account for the total RNA in each sample leads to inaccurate estimates of the true proportions of each RNA in the sample and therefore the enrichment calculated. We find that the number of RNA reads discarded is dependent on the RNA binding properties of the protein and therefore dramatically inflates background signals (e.g., RNA detected with GFP) while deflating specific signals (e.g., RNA detected with PTBP1). Importantly, we show that this issue alone explains the discrepancy between their observations and our previously reported results. The fact that PRC2 binding can only be observed when analyzed in this way further reinforces the fundamental point of our original paper: the existing evidence in support of direct PRC2-RNA binding requires critical re-evaluation.

Re-analysis of CLAP data affirms PRC2 as an RNA binding protein

PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes.

Evaluation of the RNA-dependence of PRC2 binding to chromatin in human pluripotent stem cells

Denaturing purifications demonstrate that PRC2 and other widely reported chromatin proteins do not appear to bind directly to RNA in vivo

Failing to account for RNA quantity inflates background and leads to the misleading appearance that PRC2 and GFP bind to RNA in vivo

PRC2-RNA interactions: Viewpoint from YongWoo Lee and Jeannie T. Lee

The apparent loss of PRC2 chromatin occupancy as an artefact of RNA depletion

irCLIP-RNP and Re-CLIP reveal patterns of dynamic protein associations on RNA

The apparent loss of PRC2 chromatin occupancy as an artifact of RNA depletion

Diverse RNA Structures Induce PRC2 Dimerization and Inhibit Histone Methyltransferase Activity

A Class of Protein Coding RNAs Bind to PRC2 and Regulate Histone Methylation

Prognostic value of significant and non-significant coronary artery stenosis detection using MDCT for major adverse cardiac events.

Apparent RNA bridging between PRC2 and chromatin is an artifact of non-specific chromatin precipitation upon RNA degradation

PRC2-RNA interactions: Viewpoint from Jimmy K. Guo, Mario R. Blanco, and Mitchell Guttman

Structural basis for the inhibition of PRC2 by active transcription histone posttranslational modifications

Identification of high-confidence RNA regulatory elements by combinatorial classification of RNA–protein binding sites

RNA matchmaking remodels lncRNA structure and promotes PRC2 activity

Structural basis for inactivation of PRC2 by G-quadruplex RNA

A Class of Protein-Coding RNAs Binds to Polycomb Repressive Complex 2 and Alters Histone Methylation.

sCLIP—an integrated platform to study RNA–protein interactomes in biomedical research: identification of CSTF2tau in alternative processing of small nuclear RNAs

Non-coding RNA LEVER sequestration of PRC2 can mediate long range gene regulation